Tim Smith

Nicholas (Nick) Holland focuses his practice on international contentious trusts and estates and acts primarily for wealthy families, individuals, institutional trustees, protectors and enforcers in disputes involving offshore trusts. Nick is also often involved in non-contentious international private wealth matters where he brings his extensive knowledge of offshore trusts and jurisdictions as well as potentially litigious outcomes to bear on the difficulties faced by international wealthy ...

Fiona Adams is the Managing Shareholder of the London office and the Co-Chair of the Global Corporate Practice. She primarily represents corporate clients, focusing her practice on mergers and acquisitions, and other transactional matters. Her work spans a range of industries, including pharmaceuticals, financial institutions, media and retail. Fiona has broad experience working on large, complex cross-border transactions. Fiona continues to be highly recommended by both of the leading indepe...

Neil Robson decodes complex UK and EU regulations to provide practical regulatory and compliance advice to financial services firms. He represents a range of financial market participants — hedge and private equity fund managers, investment advisors, broker-dealers and proprietary traders — that are based or doing business in the UK or the EU. Neil's extensive working knowledge of this complicated sector allows his clients to both meet their business objectives and satisfy regulat...

For more information, please visit www.gibsondunn.com/lawyer/nikpay-ali/ .

Morag Peberdy is a top attorney recognized by Best Lawyers in the practice area(s) of Life Sciences Law. Morag, who practices law in London, United Kingdom, has been recognized since 2017. This recognition is based on an exhaustive peer-review survey, reflecting the high esteem in which Morag is held by other top lawyers in the same geographic and legal practice area.

Raminta Dereskeviciute focuses her practice on product compliance, trade regulation (sanctions and export controls) and ESG. She has significant experience in advising on EU and UK chemical legislation (REACH), product safety and liability rules and frequently represents clients before the European Chemicals Agency Board of Appeal. Raminta also advises businesses on the implications Brexit has in relation to a range of regulatory compliance issues. Raminta counsels clients on the EU and the U...

Justin Watts is an experienced patent litigator who has an established and well-regarded intellectual property practice. Clients rely on his industry knowledge and years of experience to handle their complex, multinational disputes. Dr. Watts represents a variety of clients, with an emphasis on those in the pharmaceutical, medical devices, biotechnology, communications, and hardware and software industries, in disputes involving standards, competition law and patents. Dr. Watts' experience en...

Mark Fine focuses his practice on complex debt financing transactions for private equity houses, borrowers and lenders including direct lending, leveraged buyouts, domestic and cross-border syndicated lending, junior debt issuances, high yield offerings, special situations, distressed debt trading, portfolio acquisitions and restructurings. Mark has previously held the position of European General Counsel at Bain Capital Credit in London.

Eleanor West advises clients on UK and international private equity investments and buyout transactions, acting for institutions and management teams. Eleanor also advises corporate clients on cross-border merger and acquisition, joint venture and restructuring matters.

Wim De Vlieger is a partner in the London office of Gibson, Dunn & Crutcher. Mr. De Vlieger is Co-Head of Private Equity in Europe and a member of the Mergers and Acquisitions and Capital Markets practice groups. Mr. De Vlieger advises private equity investors and their portfolio companies on a wide range of corporate transactions, including growth equity and control investments and co-investments, structured transactions, buy-out transactions, mergers and acquisitions, and exits. He also...